semaglutide cv benefit Cardiovascular risk reduction with once-weekly in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline risk profile in the SUSTAIN 6 trial Indications for oral semaglutide |
Description
So this is hugely significant news, which study author Prof John Deanfield says heralds a class of drugs as powerful as statins, that could equally transform many chronic diseases of ageing
doi: 10.1038/sj.ijo.0801251
The Phase 2 trial (Jastreboff et al., NEJM 2023) tested doses from 0.5mg to 12mg
Forum Health offers a comprehensive personalized medical weight loss program that may include recommendations for semaglutide liraglutide, tirzepatide, tesofensine, naltrexone, Amlexanox, Canagliflozin, or Sermorelin
Novo Nordisk reports up to 13.8% weight loss in people with obesity receiving semaglutide in phase 2 trial
